| 000 | 01431nam a2200133Ia 4500 | ||
|---|---|---|---|
| 008 | 220620s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a9783040000000 | ||
| 245 | 0 | _aTargeting Wnt Signaling in Cancer: Opportunities Abound If We Can Avoid the Sword of Damocles | |
| 546 | _aEnglish[eng] | ||
| 650 | _aWnt signaling||synovial sarcoma||TNIK||NCB-0846||MYC||hepatitis B virus||HBV||cancer||liver cancer||β-catenin||TCF/LEF||pancreatic cancer||pancreatic stellate cells||CBP||p300||pancreatitis||fibrosis||just-right signaling||APC||colorectal cancer||RNA-binding proteins||Musashi||drug discovery||Notch signaling||cancer therapy||fungi secondary metabolite derivative||microenvironment||Wnt||AML||drug target||signaling||colorectal||porcupine||R-spondin||serrated||immunotherapy||wnt||vitamin D||colon cancer||L1||Wnt target genes||cell adhesion||NF-κB||invasion and metastasis||cancer stem cells||EMT||Lgr5||Wnt/beta-catenin signaling||angiogenesis||anti-angiogenic therapy||gastrointestinal cancers||therapeutic targeting of Wnt signaling||β-catenin paradox||molecular targeting||urothelial cancer||immune checkpoint inhibitor||immunotherapy resistance||IBD||colitis||β-catenin mutations||tumor metabolism||tumor immunology||molecular therapeutics||precision medicine||astrocytic brain tumors||DKKs||GSK3β | ||
| 700 | _aKahn, Michael||Lai, Keane | ||
| 856 | _uhttps://mdpi.com/books/pdfview/book/5245 | ||
| 942 | _cEB | ||
| 999 |
_c27265 _d27265 |
||